Sertoli-Leydig cell tumor is a rare ovarian tumor that often affects teens and young adults, though it can happen at other ages. Early symptoms of Sertoli-Leydig cell tumor can include pelvic pain, belly swelling, missed periods, or signs of higher testosterone such as more facial hair or a deeper voice. Symptoms can develop over weeks to months, but not everyone will have the same experience. Treatment usually involves surgery, and some people also need chemotherapy if the Sertoli-Leydig cell tumor is more aggressive or has spread. Many Sertoli-Leydig cell tumors are found at an early stage and have a good outlook, but survival can be lower in poorly differentiated or advanced cases.
How many people live with Sertoli-leydig cell tumor?
There is no recent, reliable published count of how many people are living with Sertoli-Leydig cell tumor, a very rare ovarian tumor, worldwide or in the United States; major sources do not report separate global or U.S. prevalence figures for it. What is well established is that it makes up less than 0.5% of ovarian tumors (WHO Classification of Female Genital Tumours, 2020), so the number of people living with it in both places is thought to be very small, but no direct count is available.
Overview
Sertoli-leydig cell tumorSymptoms
Sertoli-Leydig cell tumor may cause belly or pelvic pain, bloating, or a lump. Some people also notice missed periods, a deeper voice, extra facial hair, or other early symptoms of Sertoli-Leydig cell tumor linked to higher testosterone.
Outlook and prognosis
Many living with Sertoli-Leydig cell tumor do well when it is found early and removed with surgery, especially if it is low grade and limited to one ovary. Outlook is less favorable if it has spread or looks more aggressive under the microscope.
Causes and risk factors
Sertoli-Leydig cell tumor can be linked to changes in the DICER1 gene, sometimes inherited and sometimes new. Most cases have no clear trigger. Age, hormone-related biology, and rare family cancer syndromes may raise risk.
Genetic influences
Genetics can be important in Sertoli-Leydig cell tumor, especially changes in the DICER1 gene. Some people inherit this change, while others develop it for the first time, so genetic counseling and testing may be helpful.
Diagnosis
Sertoli-Leydig cell tumor is usually suspected after symptoms prompt a pelvic exam and ultrasound. Doctors often use blood tests and imaging, then confirm the diagnosis after surgery by examining the tumor under a microscope.
Treatment and drugs
Sertoli-Leydig cell tumor is usually treated with surgery to remove the tumor, and sometimes the ovary. Chemotherapy may be used if it has spread, comes back, or looks more aggressive under the microscope. Follow-up visits help watch hormone levels and recovery.
Symptoms
Changes in periods, new facial hair, acne, or a deepening voice can be early symptoms of Sertoli-Leydig cell tumor. Some people also develop pelvic pain, bloating, or a feeling of pressure in the lower belly as the tumor grows. Because this tumor can change hormone levels, the pattern can look different from one person to another. Symptoms vary from person to person and can change over time.
Periods may become irregular, lighter, heavier, or stop altogether. This often happens because the tumor can affect the body’s usual hormone balance.
Some people notice more facial or body hair, acne, thinning hair on the scalp, or a deeper voice. These changes can happen when the tumor makes more male-type hormones than usual.
A dull ache, cramping, or one-sided pain low in the pelvis can develop. For many, this can mean discomfort during exercise, sex, or long periods of sitting.
Bloating, fullness, or a visibly larger lower abdomen can happen as the tumor gets bigger. Clothes may start to feel tighter even without much change in weight.
How people usually first notice Sertoli-leydig cell tumor?
People usually first notice a Sertoli-Leydig cell tumor when their periods change unexpectedly, with missed periods, lighter bleeding, or bleeding stopping altogether, often along with pelvic pain, bloating, or a feeling of pressure in the lower belly. For some, the first signs of Sertoli-Leydig cell tumor are changes linked to higher testosterone levels, such as new facial or body hair, worsening acne, a deeper voice, or thinning scalp hair. Because these symptoms can look like more common hormone problems, many living with this tumor first realize something is wrong when the changes keep progressing or a clinician feels a pelvic mass or sees one on an ultrasound.
Types of Sertoli-leydig cell tumor
The types of Sertoli-Leydig cell tumor are usually based on how the tumor looks under a microscope, which often gives clues about how it may behave and what symptoms are more likely. Some tumors mainly cause hormone-related changes, while others are more likely to show up as pelvic pain, swelling, or a growing mass. Researchers describe these categories to better understand patterns of the condition. Symptoms don’t always look the same for everyone.
Well-differentiated
This is a rarer form that tends to more closely resemble normal supporting cells of the ovary. Many people with this type of Sertoli-Leydig cell tumor may notice hormone-related changes, such as missed periods, acne, or extra facial and body hair.
Intermediate differentiation
This is one of the more common forms and can cause both hormone symptoms and symptoms from the tumor itself. For many, this can mean irregular periods or signs of higher testosterone along with pelvic discomfort or a feeling of fullness.
Poorly differentiated
This type looks less like normal tissue and is generally considered more aggressive. People with poorly differentiated Sertoli-Leydig cell tumor may be more likely to have pain, abdominal swelling, or a noticeable pelvic mass, and hormone symptoms may be less obvious.
Retiform variant
This uncommon variant is seen more often in younger people and tends to have a distinct growth pattern under the microscope. It may be more likely to cause abdominal pain or a mass than clear hormone-related changes.
Heterologous variant
This type contains areas of tissue not usually found in a Sertoli-Leydig cell tumor, such as mucus-producing or muscle-like tissue. Symptoms can overlap with other variants, but some may find the tumor causes more pressure, pain, or swelling depending on its size and location.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms from a Sertoli-Leydig cell tumor, which is a rare tumor in the ovary. Healthy habits like regular exercise, good sleep, and not smoking are still important for overall health, but they have not been shown to postpone this tumor, so it is important to separate supporting general health from actually preventing the condition. If this tumor or related rare tumors run in your family, a doctor or genetics specialist may suggest early monitoring, which can help find problems sooner but does not stop the tumor from developing, and staying alert to new symptoms is a practical, honest step.
What genetics can tell you about symptoms
Genetics can offer some clues, but only to a point: some Sertoli-Leydig cell tumors are linked to changes in a gene called DICER1, and people with these changes may develop the tumor at a younger age or as part of a family pattern of related tumors. The symptoms themselves often depend more on whether the tumor is making male-type hormones and how large it is, so many living with this condition may notice irregular periods, acne, extra facial or body hair, a deeper voice, belly pain, or swelling. In other words, genetic testing may help explain why the tumor happened and whether it appeared earlier, but it usually cannot predict exactly which symptoms someone will have or how severe they will be.
Causes and risk factors
For many living with Sertoli-Leydig cell tumor, there is no single clear cause. Some cases are linked to a change in the DICER1 gene, and this change can be inherited or happen for the first time. Most Sertoli-Leydig cell tumors happen in teens and young adults, so younger age is one of the main biological risk factors. Having a gene change doesn’t mean you’ll definitely develop the condition. No lifestyle or environmental cause has been clearly proven, but doctors may ask about family history to better understand risk factors for Sertoli-Leydig cell tumor.
What are the most common causes or risk factors?
The exact cause of a Sertoli-Leydig cell tumor is often not clear, but the strongest known risk factor is a change in a gene called DICER1, which can be passed down in families or can happen only in the tumor. These tumors are seen most often in teenagers and young adults, so younger age is another important risk factor. Unlike some other cancers, there are no well-proven links to common lifestyle factors such as diet, exercise, or smoking.
Environmental and biological risk factors
Sertoli-Leydig cell tumor is a rare ovarian tumor, and the known risk factors for Sertoli-Leydig cell tumor are limited. Most people who develop it do not have one clear outside cause that can be pointed to. Doctors often group risks into internal (biological) and external (environmental).
Sertoli-Leydig cell tumor is seen more often in teenagers and young adults than in older adults. It can happen at other ages, but younger age is one of the clearest biological patterns.
This tumor starts in hormone-making support cells of the ovary, so it occurs only in people with ovarian tissue. In practical terms, the risk is tied to the biology of these cells rather than to one well-proven outside exposure.
No specific environmental exposure has been firmly shown to raise the risk of this tumor. Researchers are still studying whether outside factors play a role, but current evidence does not point to one clear trigger.
Many people have no obvious biological or environmental risk factor that can be identified. This is common with rare ovarian tumors and does not mean anything was missed or done wrong.
Genetic risk factors
Most Sertoli-Leydig cell tumors happen by chance, but a meaningful share are linked to changes in a gene called DICER1. Some people inherit a DICER1 change and have a higher chance of developing Sertoli-Leydig cell tumor, often as part of DICER1 syndrome. Carrying a genetic change doesn’t guarantee the condition will appear, and many people with this tumor do not have a known inherited cause.
Inherited DICER1: An inherited change in the DICER1 gene is the clearest known genetic risk factor for Sertoli-Leydig cell tumor. People living with DICER1 syndrome may also have a higher chance of certain other rare growths or tumors.
Tumor-only changes: Many Sertoli-Leydig cell tumors also contain DICER1 changes that arose only in the tumor cells. These changes are not passed down from a parent and usually do not mean close relatives have the same risk.
Family history: A family history of DICER1-related tumors can be a clue that Sertoli-Leydig cell tumor risk runs in the family. In some cases, genetic testing can give a clearer picture of your personal risk.
Unclear genetics: Some people with Sertoli-Leydig cell tumor have no identifiable inherited gene change on current testing. This means the genetic risk factors for Sertoli-Leydig cell tumor are not fully mapped yet, even though DICER1 is the main known gene.
Lifestyle risk factors
Lifestyle risk factors for Sertoli-Leydig cell tumor are not well defined because this is a very rare ovarian tumor and research is limited. Unlike some more common cancers, no specific diet, exercise pattern, or daily habit has been proven to directly cause it. Still, some lifestyle factors may influence hormone balance, metabolic health, or how quickly symptoms are recognized and assessed.
Obesity can change estrogen, insulin, and other hormone signals that affect ovarian tissue. This has not been proven as a direct cause of Sertoli-Leydig cell tumor, but poor metabolic health may create a less favorable hormonal environment.
Low activity levels often contribute to weight gain, insulin resistance, and chronic low-grade inflammation. These changes are part of how lifestyle affects Sertoli-Leydig cell tumor risk in theory, although a direct link has not been firmly shown.
Smoking is harmful to overall reproductive and cancer health and may damage cells through oxidative stress and other mechanisms. However, smoking has not been established as a specific lifestyle risk factor for Sertoli-Leydig cell tumor.
Heavy alcohol use can disrupt hormone metabolism and worsen general cancer-related health risks. For Sertoli-Leydig cell tumor specifically, current evidence does not show a clear causal relationship.
Risk prevention
There is no proven way to fully prevent Sertoli-Leydig cell tumor, and most cases happen without a clear avoidable cause. For many living with concerns about family cancer risk, prevention is more about finding inherited risk, staying alert to changes, and catching problems early rather than stopping the tumor from ever forming. Some prevention is tailored to people with specific risks. This matters most for families with a DICER1 gene change, which can raise the chance of Sertoli-Leydig cell tumor and some other tumors.
If Sertoli-Leydig cell tumor runs in your family, or if there is a known DICER1 gene change, genetic counseling can help clarify personal risk. Testing may identify people who need closer follow-up, even though it cannot guarantee prevention.
People with a DICER1-related risk may be advised to have regular check-ins with a specialist and, in some cases, pelvic imaging based on age and family history. This does not prevent Sertoli-Leydig cell tumor itself, but it can help find related problems earlier.
Paying attention to early symptoms of Sertoli-Leydig cell tumor can lead to faster care. Many notice ongoing belly or pelvic pain, swelling, irregular periods, or unexpected signs of higher testosterone such as increased facial hair or a deeper voice.
New pelvic symptoms should not be brushed off as stress, hormones, or a routine ovarian cyst if they keep coming back. Early medical assessment can help sort out harmless causes from rare tumors such as Sertoli-Leydig cell tumor.
Can you prevent Sertoli-leydig cell tumor?
In most cases, no, there is no known way to prevent a Sertoli-Leydig cell tumor because this rare tumor usually happens without a clear cause you can control. Some cases are linked to an inherited gene change, and that cannot be prevented, although genetic counseling may help families understand their risk. Paying attention to new symptoms and getting them checked sooner may help find the tumor earlier, but it does not stop it from forming.
Transmission
Sertoli-Leydig cell tumor is not infectious, so it cannot spread from one person to another through touching, kissing, sex, blood, or sharing food, bathrooms, or everyday spaces. Most Sertoli-Leydig cell tumors happen sporadically, which means they develop by chance and are not passed through families.
In a smaller number of cases, the tumor is linked to an inherited change in a gene called DICER1, so how Sertoli-Leydig cell tumor is inherited matters mainly as a question of family risk, not contagion. Even then, a parent can pass down the gene change, but that does not mean a child will definitely develop a Sertoli-Leydig cell tumor.
When to test your genes
If you have a Sertoli-Leydig cell tumor, genetic testing is often recommended because some are linked to changes in the DICER1 gene. It is especially important at a young age or if you or your family have had thyroid, lung, kidney, or ovarian tumors, since results can guide screening and family care.
Diagnosis
Sertoli-Leydig cell tumor is usually suspected when symptoms such as pelvic pain, a growing abdominal fullness, or changes linked to higher male-type hormone levels lead to a medical visit. Some people notice irregular periods, new facial hair, acne, or a deeper voice, while others learn about it after an ovarian mass is found on imaging. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of Sertoli-Leydig cell tumor is made by combining the exam, imaging, lab tests, and the tumor tissue itself.
Doctors ask about symptoms, menstrual changes, pelvic pain, and any signs of higher androgen levels such as increased facial hair or voice changes. A detailed family and health history can help identify clues that suggest a rare ovarian tumor or an inherited risk.
A pelvic exam can sometimes detect an enlarged ovary or a mass in the pelvis. This helps guide the next steps, although smaller tumors may not be felt on exam.
Pelvic ultrasound is often the first imaging test used to look at the ovaries and nearby structures. It can show whether a mass is present and whether it appears solid, cystic, or mixed.
CT or MRI scans may be used to look more closely at the ovarian mass and check whether the tumor has spread. These scans can help with surgical planning and support how Sertoli-Leydig cell tumor is diagnosed.
How is Sertoli-leydig cell tumor diagnosed?
Doctors usually suspect a Sertoli-Leydig cell tumor based on symptoms, a pelvic exam, and imaging tests, most often an ultrasound and sometimes a CT or MRI scan, to look closely at the ovary and any growth. Blood tests may also be used to check hormone levels, since these tumors can make extra male-type hormones, and sometimes to check other signs linked to an ovarian tumor. A definite diagnosis is usually made only after the tumor is removed, or a sample is taken, and examined under a microscope, and some people, especially younger people or those with a family history, may also be offered genetic testing for an inherited change called DICER1.
Stages of Sertoli-leydig cell tumor
Sertoli-Leydig cell tumor is usually described by stage, which tells you how far the tumor has spread at the time of diagnosis. Most are found at an early stage, often because symptoms such as pelvic pain, a growing abdominal swelling, or hormone-related changes lead to testing. Early and accurate diagnosis helps you plan ahead with confidence. Doctors work out the stage using surgery, imaging scans, and lab tests, especially when checking possible early symptoms of Sertoli-Leydig cell tumor.
Stage I
The tumor is only in one or both ovaries. For many living with Sertoli-Leydig cell tumor, this is the most common stage at diagnosis.
Stage II
The tumor has spread from the ovary into nearby structures in the pelvis, such as the uterus, fallopian tubes, bladder lining, or tissue around the rectum. It is still limited to the pelvic area.
Stage III
Sertoli-Leydig cell tumor has spread outside the pelvis into the lining of the abdomen or nearby lymph nodes. Some may also have fluid in the abdomen with tumor cells present.
Stage IV
The tumor has spread to distant parts of the body, such as the liver tissue or lungs. This is the most advanced stage and usually needs more extensive treatment.
Outlook and prognosis
The outlook for people with Sertoli-Leydig cell tumor is generally favorable when the tumor is found at an early stage and completely removed, with most low-grade, stage I cases having excellent long-term survival. Prognosis depends mainly on stage, degree of differentiation, tumor rupture, and the presence of heterologous elements or retiform features, which are linked to a higher risk of recurrence and spread. Well-differentiated tumors are often benign or have low malignant potential, while poorly differentiated tumors behave more aggressively. Most recurrences occur within the first few years after treatment, so close follow-up is especially important during that period. Mortality is low for localized disease but rises substantially in advanced-stage or high-grade tumors. Overall, early diagnosis and complete surgical management offer the best chance of cure.
Long-term effects
For many people, the long-term effects of a Sertoli-Leydig cell tumor depend on whether the tumor was found early, whether it spread, and what treatment was needed. Many living with Sertoli-Leydig cell tumor do well after treatment, especially when the tumor is confined to one ovary, but follow-up still matters because some tumors can come back. Thinking about the long-term effects helps explain why doctors keep checking hormone levels, menstrual patterns, and general health over time.
One of the main long-term concerns with Sertoli-Leydig cell tumor is that it can sometimes return after treatment. This risk is usually higher when the tumor is more aggressive, has spread beyond the ovary, or has certain unusual features under the microscope.
Treatment may affect fertility, especially if both ovaries are involved or if chemotherapy is needed. Some people still become pregnant after treatment, while others may find their options are more limited and need specialist advice.
These tumors can change hormone levels, which may lead to long-term changes in periods, body hair, acne, or voice deepening. In many cases these changes improve after the tumor is removed, but some features can last if hormone effects were strong or went on for a while.
If treatment removes both ovaries or damages ovarian function, early menopause can happen. For many, this can mean hot flashes, vaginal dryness, sleep problems, and a higher long-term risk of bone thinning.
How is it to live with Sertoli-leydig cell tumor?
Living with a Sertoli-Leydig cell tumor can feel unsettling because the changes often reach beyond the pelvis: many people are coping not only with pain, bloating, or an abdominal mass, but also with hormone-related changes such as irregular periods, acne, extra facial or body hair, or a deeper voice. Daily life may be affected by fatigue, worry about fertility, surgery, and the need for follow-up visits, while emotionally it can be hard to adjust to symptoms that change how your body looks or feels. For partners, family, and close friends, the impact often shows up as shared stress, extra caregiving, and concern about treatment and future plans, but clear medical guidance and support can help people regain a sense of control.
Treatment and drugs
Sertoli-Leydig cell tumor is usually treated first with surgery, because removing the tumor is the main way to treat it and also helps confirm exactly what type it is. For many living with Sertoli-Leydig cell tumor, treatment decisions also depend on age, whether the tumor has spread, and whether preserving fertility is important. If the cancer is higher risk, has spread, or comes back after surgery, doctors may recommend chemotherapy, often using a combination of medicines given over several cycles. Not every treatment works the same way for every person, and follow-up visits with scans, blood tests, and pelvic exams are often part of care after treatment. Supportive care can make a real difference in how you feel day to day, especially if you are dealing with pain, fatigue, hormone-related symptoms, or the stress of recovery.
Can you cure Sertoli-leydig cell tumor?
Sertoli-Leydig cell tumor can often be cured, especially when it is found early and removed with surgery. If it has spread or comes back, a cure may be harder, but treatment such as surgery and chemotherapy can still help control the cancer and lower symptoms. The outlook varies from person to person, so the care team can explain what treatment is most likely to help in that situation.
Non-drug treatment
For many living with Sertoli-Leydig cell tumor, treatment often centers on procedures and supportive care rather than medicines alone. Surgery is the main non-drug treatment, and the exact approach depends on the tumor’s size, stage, and whether future fertility matters. Because these tumors can affect hormone levels, some people first notice changes like irregular periods, new facial hair, or a deeper voice before treatment begins. Managing this condition often also includes follow-up imaging, lab checks, and counseling to support recovery and long-term health.
Surgery is the main treatment for Sertoli-Leydig cell tumor and is used to remove the tumor and confirm the diagnosis. For some, this may mean removing one ovary, while others may need a more extensive operation depending on spread and childbearing plans.
If the tumor is found early and limited to one ovary, fertility-sparing surgery may be possible for people who hope to become pregnant later. Structured planning, like meeting with a gynecologic cancer surgeon before the operation, can help balance cancer treatment with fertility goals.
These tumors can make male-type hormones, so care often includes tracking symptoms and hormone levels before and after treatment. This can help explain changes such as missed periods, acne, or voice deepening and show whether they improve over time.
Regular follow-up visits are an important part of non-drug treatment after surgery. Monitoring may include pelvic exams, imaging scans, and blood tests to watch for recurrence, especially during the first few years when return is more likely to be found.
Your genes may have an impact on how drugs work for you
For Sertoli-Leydig cell tumor, treatment is usually based more on the tumor’s stage, appearance, and whether surgery can remove it than on a person’s genes. If chemotherapy is needed, people can respond differently, and part of that may come from small inherited differences that affect how the body breaks down medicines or how sensitive it is to side effects, but there is no widely used genetic test that routinely picks the best drug for this tumor. In other words, drug-gene testing, sometimes called pharmacogenomics, is not a standard part of care for most people living with Sertoli-Leydig cell tumor, though it may become more helpful as research grows.
Pharmacological treatments
For many people with Sertoli-Leydig cell tumor, surgery is the main treatment, and medicines are usually considered when the tumor has spread, come back, or has higher-risk features under the microscope. The most commonly used drug treatment is chemotherapy, especially for recurrent or advanced Sertoli-Leydig cell tumor. Not everyone responds to the same medication in the same way, so the exact plan often depends on age, stage, fertility goals, and the tumor’s pathology.
Bleomycin, etoposide, and cisplatin are a well-known combination used for some Sertoli-Leydig cell tumors that are advanced, recurrent, or considered high risk. This regimen aims to kill fast-growing cancer cells, but it can cause side effects such as nausea, fatigue, lowered blood counts, nerve symptoms, or lung problems, so close monitoring is important.
Carboplatin and paclitaxel are another chemotherapy pair that may be used, especially when doctors want an alternative to BEP or when a person’s overall health makes a different balance of side effects preferable. These drugs can be effective in some ovarian sex cord-stromal tumors, although the evidence in Sertoli-Leydig cell tumor is more limited because the condition is rare.
Medicines such as ondansetron or other anti-nausea drugs, growth factor shots to support blood counts, and pain relievers are often given alongside chemotherapy. Alongside drug therapy, follow-up visits and blood tests remain important so side effects can be managed early.
In unusual situations, treatment may be individualized based on what the tumor looks like under the microscope, such as adding different chemotherapy if there are mixed tissue elements. If one option isn’t effective, second-line or alternative drugs may be offered, but there is no single standard medicine used for every recurrent case.
Genetic influences
When a Sertoli-Leydig cell tumor is diagnosed, many families want to know whether it may be linked to an inherited gene change. It’s natural to ask whether family history plays a role. In some people, Sertoli-Leydig cell tumor is associated with a change in a gene called DICER1, and this change can be inherited from a parent or happen for the first time in the tumor or in the person affected. Many living with this tumor, though, do not have a known inherited cause, so genetics is important but not the whole story.
This matters in everyday care because a young age at diagnosis, a personal history of other unusual tumors, or relatives with similar conditions can make doctors think more strongly about an inherited risk. If that pattern is present, genetic counseling and DICER1 testing may help clarify whether other family members could also be at risk. A positive result does not predict exactly what will happen, but it can help guide follow-up and screening for the person with Sertoli-Leydig cell tumor and, in some cases, for close relatives.
Is Sertoli-leydig cell tumor genetic?
Genetics can be important in Sertoli-Leydig cell tumor, especially changes in the DICER1 gene. Some people inherit this change, while others develop it for the first time, so genetic counseling and testing may be helpful.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of being human and are common throughout the general population. Most do not have any direct effect on health and simply reflect natural variation among people. For many genes, having a variant connected with a condition suggests a possible association, not a certain diagnosis, especially when several genes and environmental factors play a role. In some cases, though, a single well-understood variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with Sertoli-Leydig cell tumor, genetic testing matters less for choosing a specific drug and more for understanding the bigger treatment picture. A change in a gene called DICER1 is found in some of these tumors, and sometimes that change is inherited, which can help doctors confirm the diagnosis and plan follow-up care. Genetics is only one factor, and for Sertoli-Leydig cell tumor the main treatment decisions are still usually based on the tumor’s stage, how abnormal the cells look under the microscope, whether it has spread, and a person’s age and fertility goals. If chemotherapy is needed, there is no widely used pharmacogenetic test that reliably tells doctors which standard medicines will work best for this tumor. Still, finding an inherited DICER1 change can lead to extra screening for other related tumors and may help close relatives decide whether they want genetic counseling or testing.
Interactions with other conditions
For many living with Sertoli-Leydig cell tumor, the bigger issue is often that its hormone-related changes can look like other conditions at first. Extra androgen production may cause acne, increased facial or body hair, missed periods, or a deeper voice, so it can be confused with polycystic ovary syndrome or, less often, adrenal gland disorders. Doctors call it a “comorbidity” when two conditions occur together, and that can make the picture harder to sort out if someone already has another hormone or menstrual condition. Sertoli-Leydig cell tumor may also be linked with an inherited condition involving the DICER1 gene, which raises the chance of certain other growths or tumors in organs such as the thyroid, lungs, or kidneys. This means the early symptoms of Sertoli-Leydig cell tumor sometimes need to be interpreted alongside personal and family history, especially if there have been unusual tumors at a young age. If there is concern for overlap, doctors may suggest blood hormone tests, imaging, and sometimes genetic counseling to make sure another disease is not being missed.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Sertoli-leydig cell tumor?
The symptoms of a Sertoli-Leydig cell tumor can overlap with polycystic ovary syndrome, especially when someone has irregular periods, acne, or more facial and body hair than usual. Other ovarian growths, such as common cysts or other ovarian tumors, can also cause pelvic pain, belly swelling, or changes in bleeding. Less often, problems in the adrenal glands, which also make hormones, can cause similar hormone-related changes, so doctors usually check for these too.
History
For many living with Sertoli-Leydig cell tumor, the history of this condition helps explain why it can still feel unfamiliar today. These tumors were recognized only gradually, because they are uncommon and can affect hormone levels as well as the ovary itself. Early doctors usually described what they could see under the microscope and what patients were experiencing, such as changes in periods, trouble becoming pregnant, or signs of higher male-type hormone levels like increased facial hair or a deeper voice.
In the early 20th century, pathologists began separating Sertoli-Leydig cell tumor from other ovarian growths after noticing that some tumors contained cells resembling those normally involved in hormone-making tissues. At first, naming was not consistent, and older reports used different labels for similar tumors. Over time, the way the condition has been understood has changed, and clearer classification helped doctors recognize that Sertoli-Leydig cell tumor is part of a small group of sex cord-stromal tumors of the ovary rather than a more common ovarian cancer.
As laboratory methods improved, specialists learned that these tumors can behave quite differently from one person to another. Some are found at an early stage and may cause noticeable hormone-related symptoms, while others are discovered because of pelvic pain, abdominal swelling, or an ovarian mass seen on imaging. This growing understanding also shaped how doctors talk about early symptoms of Sertoli-Leydig cell tumor, especially in younger people, since these tumors can appear earlier in life than many other ovarian tumors.
More recently, research has connected some cases of Sertoli-Leydig cell tumor to underlying genetic changes, which helped explain why the condition can vary so much between families and individuals. Even so, the main story of its history is one of better recognition: what was once a confusing and inconsistently named ovarian tumor is now more clearly identified, classified, and studied. Knowing this background can make it easier to understand why diagnosis often depends on a careful mix of symptoms, imaging, surgery, and expert review of the tumor tissue.